{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T17:04:29Z","timestamp":1776963869140,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000921","name":"COST","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"NKFIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jinorgbio.2022.112058","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T12:10:32Z","timestamp":1667391032000},"page":"112058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Ruthenium(II) polypyridyl complexes with benzothiophene and benzimidazole derivatives: Synthesis, antitumor activity, solution studies and biospeciation"],"prefix":"10.1016","volume":"238","author":[{"given":"Orsolya","family":"D\u00f6m\u00f6t\u00f6r","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo G.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Spengler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Avecilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar A.","family":"Lenis-Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina P.","family":"Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo F.M.","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9va A.","family":"Enyedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Isabel","family":"Tomaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2022.112058_bb0005","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/ejic.201601278","article-title":"Platinum(IV) prodrugs \u2013 a step closer to Ehrlich\u2019s vision?","volume":"12","author":"Kenny","year":"2017","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mpmed.2007.10.012","article-title":"Cytotoxic chemotherapy: clinical aspects","volume":"36","author":"Corrie","year":"2008","journal-title":"Medicine"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0015","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1158\/0008-5472.CAN-09-2422","article-title":"Identification of compounds selectively killing multidrug-resistant cancer cells","volume":"69","author":"T\u00fcrk","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0020","first-page":"134","article-title":"Principles of cancer treatment by chemotherapy","volume":"36","author":"Dickens","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0025","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1021\/cr4006236","article-title":"Targeting the achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance","volume":"114","author":"Szak\u00e1cs","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0030","doi-asserted-by":"crossref","first-page":"100778","DOI":"10.1016\/j.drup.2021.100778","article-title":"Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance","volume":"58","author":"Valente","year":"2021","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jinorgbio.2011.09.030","article-title":"Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates","volume":"106","author":"Bergamo","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2018.01.009","article-title":"The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions","volume":"360","author":"Bergamo","year":"2018","journal-title":"Coord. Chem. Rev."},{"issue":"10","key":"10.1016\/j.jinorgbio.2022.112058_bb0045","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.3390\/molecules24101995","article-title":"NAMI-A and KP1019\/1339, two iconic ruthenium anticancer drug candidates face-to-face: a case story in medicinal inorganic chemistry","volume":"24","author":"Alessio","year":"2019","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.jinorgbio.2022.112058_bb0050","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/acs.chemrev.8b00211","article-title":"Transition metal complexes and photodynamic therapy from a tumor-centered epproach: challenges, opportunities, and highlights from the development of TLD1433","volume":"119","author":"Monro","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0055","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ccr.2015.06.014","article-title":"The development of RAPTA compounds for the treatment of tumors","volume":"306","author":"Murray","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0065","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1039\/C7CS00356K","article-title":"Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(II) polypyridyl complexes as anticancer drug candidates","volume":"46","author":"Notaro","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jinorgbio.2016.12.008","article-title":"Studies on the mechanism of action of antitumor bis(aminophenolate) ruthenium(III) complexes","volume":"168","author":"D\u00f6m\u00f6t\u00f6r","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0075","series-title":"Synthetic Inorganic Chemistry - New Perspectives","first-page":"223","article-title":"Chapter 6 - Ruthenium and iron metallodrugs: new inorganic and organometallic complexes as prospective anticancer agents","author":"Valente","year":"2021"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0080","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ccr.2018.02.013","article-title":"Biological applications of Ru(II) polypyridyl complexes","volume":"375","author":"Mital","year":"2018","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0085","doi-asserted-by":"crossref","first-page":"13040","DOI":"10.1039\/C8CC05928D","article-title":"Mechanisms of action of Ru(II) polypyridyl complexes in living cells upon light irradiation","volume":"54","author":"Jakubaszek","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0090","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1039\/C3SC53243G","article-title":"NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application","volume":"5","author":"Trondl","year":"2014","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0095","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1021\/jm010051m","article-title":"Inhibition of cancer cell growth by ruthenium(II) arene complexes","volume":"44","author":"Morris","year":"2001","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.jinorgbio.2022.112058_bb0100","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/ejic.201601216","article-title":"The fate of cycloruthenated compounds: from C-H activation to innovative anticancer therapy","volume":"2017","author":"Gaiddon","year":"2017","journal-title":"Eur. J. Inorg. Chem."},{"issue":"21","key":"10.1016\/j.jinorgbio.2022.112058_bb0105","doi-asserted-by":"crossref","first-page":"13150","DOI":"10.1021\/acs.inorgchem.8b01270","article-title":"RuII(p-cymene) compounds as effective and selective anticancer candidates with no toxicity in vivo","volume":"57","author":"Lenis-Rojas","year":"2018","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0110","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jinorgbio.2015.06.015","article-title":"The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: ranging from non-cytotoxic to highly cytotoxic compounds","volume":"150","author":"C\u00f4rte-Real","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0115","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1017\/S143192761300175X","article-title":"Cellular uptake mechanisms of an antitumor ruthenium compound: the endosomal\/lysosomal system as a target for anticancer metal-based drugs","volume":"19","author":"C\u00f4rte-Real","year":"2013","journal-title":"Microsc. Microanal."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0120","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ejmech.2018.12.022","article-title":"Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl compound bearing a bipyridine-biotin ligand","volume":"163","author":"C\u00f4rte-Real","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0125","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1039\/C7CS00195A","article-title":"The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials","volume":"46","author":"Zeng","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0130","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1039\/C9CC04098F","article-title":"Functionalization and cancer-targeting design of ruthenium complexes for precise cancer therapy","volume":"55","author":"Liu","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0135","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1039\/C7SC02205K","article-title":"Cytotoxic (salen)ruthenium(III) anticancer complexes exhibit different modes of cell death directed by axial ligands","volume":"8","author":"Li","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0140","doi-asserted-by":"crossref","first-page":"11963","DOI":"10.1016\/j.jinorgbio.2022.111963","article-title":"Synthesis and characterization of polypyridine ruthenium(II) complexes and anticancer effcacy studies in vivo and in vitro","volume":"236","author":"Liang","year":"2022","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0145","doi-asserted-by":"crossref","first-page":"8916","DOI":"10.3390\/ijms22168916","article-title":"Evaluation of the in vitro and in vivo efficacy of ruthenium polypyridyl compounds against breast cancer","volume":"22","author":"Lenis-Rojas","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0150","doi-asserted-by":"crossref","first-page":"10459","DOI":"10.1021\/acs.jmedchem.2c00580","article-title":"Inhibition of metastasis by polypyridyl Ru(II) complexes through modification of cancer cell adhesion \u2013 in vitro functional and molecular studies","volume":"65","author":"Gurgul","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0155","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1039\/D0QI01344G","article-title":"Unprecedented collateral sensitivity for cisplatin-resistant lung cancer cells presented by new ruthenium organometallic compounds","volume":"8","author":"Teixeira","year":"2021","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0160","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1002\/chem.201904877","article-title":"A maltol-containing ruthenium polypyridyl complex as a potential anticancer agent","volume":"26","author":"Notaro","year":"2020","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0165","doi-asserted-by":"crossref","first-page":"31973","DOI":"10.1038\/srep31973","article-title":"A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition","volume":"6","author":"Gill","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/cbdd.12462","article-title":"Comprehensive review in current developments of benzimidazole-based medicinal chemistry","volume":"86","author":"Keri","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0175","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.bmcl.2003.12.051","article-title":"Synthesis and biological evaluations of novel benzimidazoles as potential antibacterial agents","volume":"14","author":"He","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0180","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cclet.2012.04.020","article-title":"Synthesis, biological evaluation and SAR studies of benzimidazole derivatives as H1-antihistamine agents","volume":"23","author":"Wang","year":"2012","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/1389557053544047","article-title":"Imidazole and benzimidazole derivatives as chemotherapeutic agents","volume":"5","author":"Boiani","year":"2005","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s43094-020-00048-8","article-title":"Versatile mechanisms of 2-substituted benzimidazoles in targeted cancer therapy","volume":"6","author":"Ibrahim","year":"2020","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0195","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ejmech.2017.07.038","article-title":"An overview of benzo[b]thiophene-based medicinal chemistry","volume":"138","author":"Keri","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0200","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.1039\/D0DT04258G","article-title":"Synthesis of ruthenium complexes functionalized with benzothiophene and their antibacterial activity against Staphylococcus aureus","volume":"50","author":"Liao","year":"2021","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0205","doi-asserted-by":"crossref","first-page":"8539","DOI":"10.1039\/C7DT00938K","article-title":"Ruthenium(II) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies","volume":"46","author":"Bhattacharyya","year":"2017","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0210","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1021\/acs.jmedchem.5b01194","article-title":"Novel C,N-cyclometalated benzimidazole ruthenium(II) and iridium(III) complexes as antitumor and antiangiogenic agents: a structure\u2013activity relationship study","volume":"58","author":"Yellol","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0215","doi-asserted-by":"crossref","first-page":"10113","DOI":"10.3390\/ijms221810113","article-title":"Uthenium complexes with 2-pyridin-2-yl-1 H-benzimidazole as potential antimicrobial agents: correlation between chemical properties and anti-biofilm effects","volume":"22","author":"Jab\u0142onska-Wawrzycka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0220","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.talanta.2003.09.001","article-title":"Synthesis and characterization of electrochemiluminescent ruthenium(II) complexes containing o-phenanthroline and various alpha-diimine ligands","volume":"62","author":"Kim","year":"2004","journal-title":"Talanta"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0225","doi-asserted-by":"crossref","first-page":"11918","DOI":"10.1039\/D1DT01700D","article-title":"Critical factors affecting the albumin binding of half-sandwich Ru(II) and Rh(III) complexes of 8-hydroxyquinolines and oligopyridines","volume":"50","author":"D\u00f6m\u00f6t\u00f6r","year":"2021","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0230","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00775-019-01683-0","article-title":"Binding mechanisms of half-sandwich Rh(III) and Ru(II) arene complexes on human serum albumin: a comparative study","volume":"24","author":"D\u00f6m\u00f6t\u00f6r","year":"2019","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0235","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1021\/om7008843","article-title":"Ligand effects of 2-(2-pyridyl)benzazole\u2212Pd complexes on the X-ray crystallographic structures, 1H NMR spectra, and catalytic activities in Mizoroki\u2212Heck reactions","volume":"26","author":"Haneda","year":"2007","journal-title":"Organometallics"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0240","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1039\/b208289f","article-title":"Ruthenium complexes of 2-(2\u2032-pyridyl)benzimidazole as photosensitizers for dye-sensitized solar cells","author":"Yi","year":"2003","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0245","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.jinorgbio.2006.07.008","article-title":"Interaction of \u039b- and \u0394-[Ru(bpy)2(pbmz)](PF6)2 with the oligonucleotide duplex d(CGCGAATTCGCG)2","volume":"100","author":"Papakyriakou","year":"2006","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0250","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/chem.201002149","article-title":"Photoactive RuII\u2013polypyridyl complexes that display sequence selectivity and high-affinity binding to duplex DNA through groove binding","volume":"17","author":"Ghosh","year":"2011","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0020-1693(00)91186-1","article-title":"Synthesis and protonation-deprotonation reactions of ruthenium(II) complexes containing 2, 2\u2032-bibenzimidazole and related ligands","volume":"75","author":"Akihaga","year":"1983","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0260","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.3390\/molecules16108353","article-title":"Synthesis, photophysical and electrochemical properties of a mixed bipyridyl-phenanthrolyl ligand Ru(II) heteroleptic complex having trans-2-methyl-2-butenoic acid functionalities","volume":"16","author":"Adeloye","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0265","doi-asserted-by":"crossref","first-page":"9312","DOI":"10.1039\/b906756f","article-title":"DNA binding and cleavage properties of a newly synthesised Ru(II)-polypyridyl complex","author":"Ghosh","year":"2009","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0270","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/0039-9140(96)01958-3","article-title":"Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs","volume":"43","author":"Gans","year":"1996","journal-title":"Talanta"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0275","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1139\/v92-108","article-title":"Prototropic equilibria of 2-pyridylbenzimidazoles in aqueous solution","volume":"70","author":"Novo","year":"1992","journal-title":"Can. J. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0280","doi-asserted-by":"crossref","first-page":"246","DOI":"10.5603\/OCP.2019.0024","article-title":"Characteristics of in vitro model systems for ovarian cancer studies","volume":"15","author":"Tudrej","year":"2019","journal-title":"Oncol. Clin. Pract."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0285","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/138161206775201965","article-title":"An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy","volume":"12","author":"Takara","year":"2006","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0290","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138161282005140214165212","article-title":"ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development","volume":"20","author":"Choi","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0295","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1039\/D1DT00808K","article-title":"Half-sandwich organometallic Ru and Rh complexes of (N,N) donor compounds: effect of ligand methylation on solution speciation and anticancer activity","volume":"50","author":"M\u00e9sz\u00e1ros","year":"2021","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0300","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1158\/1535-7163.MCT-16-0333-T","article-title":"Identification and validation of compounds selectively killing resistant cancer: delineating cell line-specific effects from P-glycoprotein-induced toxicity","volume":"16","author":"F\u00fcredi","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0305","first-page":"3245","article-title":"Reversal of ABCB1-related multidrug resistance of colonic adenocarcinoma cells by phenothiazines","volume":"35","author":"Tak\u00e1cs","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0310","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: from bench to bedside","volume":"33","author":"Fanali","year":"2012","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0315","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1039\/C8CS00157J","article-title":"Molecular methods for assessment of non-covalent metallodrug\u2013DNA interactions","volume":"48","author":"Kellett","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0320","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1039\/C4DT02700K","article-title":"Metal complex interactions with DNA","volume":"44","author":"Pages","year":"2015","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0325","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0301-4622(93)E0101-A","article-title":"Fluorescence lifetime analysis of DNA intercalated ethidium bromide and quenching by free dye","volume":"50","author":"Heller","year":"1994","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0330","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/bip.1975.360140114","article-title":"Ethidium bromide\u2013dinucleotide complexes. Evidence for intercalation and sequence preferences in binding to double-stranded nucleic acids","volume":"14","author":"Krugh","year":"1975","journal-title":"Biopolymers"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0335","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0301-4622(97)00091-4","article-title":"Photophysics of ethidium bromide complexed to ct-DNA: a maximum entropy study","volume":"70","author":"Byrne","year":"1998","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0340","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.1021\/jp9824914","article-title":"DNA binding geometries of ruthenium(II) complexes with 1,10-phenanthroline and 2,2\u2032-bipyridine ligands studied with linear dichroism spectroscopy. Borderline cases of intercalation","volume":"102","author":"Lincoln","year":"1998","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0345","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1021\/ja00038a085","article-title":"Minor groove binding of [Ru(phen)3]2+ to [d(CGCGATCGCG)]2 evidenced by two-dimensional NMR","volume":"114","author":"Eriksson","year":"1992","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0350","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1021\/bi00459a006","article-title":"Structural examination of enantioselective intercalation: 1H NMR of Rh(en)2phi3+ isomers bound to d(GTGCAC)2","volume":"29","author":"Rehmann","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0355","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1016\/S0006-3495(03)74801-2","article-title":"DNA mediated resonance energy transfer from 4\u2032,6-diamidino-2-phenylindole to [Ru(1,10-phenanthroline)2L]2+","volume":"85","author":"Lee","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0360","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00775-012-0944-6","article-title":"Characterization of the binding sites of the anticancer ruthenium(III) complexes KP1019 and KP1339 on human serum albumin via competition studies","volume":"18","author":"D\u00f6m\u00f6t\u00f6r","year":"2013","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0365","series-title":"Current Protocols in Molecular Biology","article-title":"Quantitation of DNA and RNA with absorption and fluorescence spectroscopy","author":"Gallagher","year":"1994"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0370","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1021\/ic50190a006","article-title":"Mixed phosphine 2,2\u2032-bipyridine complexes of ruthenium","volume":"17","author":"Sullivan","year":"1978","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0375","series-title":"SADABS (Version 2.10)","author":"Sheldrick","year":"2004"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0380","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2: a complete structure solution, refinement and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0385","first-page":"59","article-title":"The anatomy of a comprehensive constrained, restrained refinement program for the modern computing environment \u2013 Olex2 dissected","volume":"A71","author":"Bourhis","year":"2015","journal-title":"Acta Cryst"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0390","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jpba.2018.03.011","article-title":"Comparative studies on the human serum albumin binding of the clinically approved EGFR inhibitors gefitinib, erlotinib, afatinib, osimertinib and the investigational inhibitor KP2187","volume":"154","author":"D\u00f6m\u00f6t\u00f6r","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0395","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jpba.2010.12.025","article-title":"Lipophilicity of kinetically labile metal complexes through the example of antidiabetic Zn(II) and VO(IV) compounds","volume":"54","author":"Enyedy","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0400","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s11095-007-9517-8","article-title":"A novel design of artificial membrane for improving the PAMPA model","volume":"25","author":"Chen","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0405","article-title":"A new PAMPA model proposed on the basis of a synthetic phospholipid membrane","volume":"10","author":"Yu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jinorgbio.2022.112058_bb0410","series-title":"Principles of Fluorescence Spectroscopy","author":"Lakowicz","year":"2006"}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013422003476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013422003476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:12:10Z","timestamp":1758985930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013422003476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":82,"alternative-id":["S0162013422003476"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2022.112058","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ruthenium(II) polypyridyl complexes with benzothiophene and benzimidazole derivatives: Synthesis, antitumor activity, solution studies and biospeciation","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2022.112058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112058"}}